Literature DB >> 23662598

TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.

Khanh-Quynh Nguyen1, Wen-I Tsou, Sergei Kotenko, Raymond B Birge.   

Abstract

Receptor tyrosine kinases, Tyro-3, Axl and Mer, collectively designated as TAM, are involved in the clearance of apoptotic cells. TAM ligands, Gas6 and Protein S, bind to the surfaces of apoptotic cells, and at the same time, interact directly with TAM expressed on phagocytes, impacting the engulfment and clearance of apoptotic cells and debris. The well-tuned and balanced actions of TAM may affect a variety of human pathologies including autoimmunity, retinal degeneration, and cancer. This article emphasizes some of the emerging findings and mechanistic insights into TAM functions that are clinically relevant and possibly therapeutically targeted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23662598     DOI: 10.3109/08916934.2013.794515

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  21 in total

Review 1.  Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer.

Authors:  Bénédicte Fauvel; Aziz Yasri
Journal:  MAbs       Date:  2014-05-14       Impact factor: 5.857

2.  Dying autologous cells as instructors of the immune system.

Authors:  L E Munoz; M Herrmann; C Berens
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

3.  Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction.

Authors:  L Xu; F Hu; H Zhu; X Liu; L Shi; Y Li; H Zhong; Y Su
Journal:  Clin Exp Immunol       Date:  2017-12-11       Impact factor: 4.330

Review 4.  TGF-β1-induced transcription factor networks in Langerhans cell development and maintenance.

Authors:  X Zhang; J Gu; F-S Yu; L Zhou; Q-S Mi
Journal:  Allergy       Date:  2016-04-15       Impact factor: 13.146

5.  An improved method for differentiating cell-bound from internalized particles by imaging flow cytometry.

Authors:  Asya Smirnov; Michael D Solga; Joanne Lannigan; Alison K Criss
Journal:  J Immunol Methods       Date:  2015-05-09       Impact factor: 2.303

6.  The expression of inflammatory cytokines, TAM tyrosine kinase receptors and their ligands is upregulated in venous leg ulcer patients: a novel insight into chronic wound immunity.

Authors:  Kata Filkor; Tibor Németh; István Nagy; Éva Kondorosi; Edit Urbán; Lajos Kemény; Győző Szolnoky
Journal:  Int Wound J       Date:  2015-07-20       Impact factor: 3.315

7.  Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.

Authors:  Wen-I Tsou; Khanh-Quynh N Nguyen; Daniel A Calarese; Scott J Garforth; Anita L Antes; Sergey V Smirnov; Steve C Almo; Raymond B Birge; Sergei V Kotenko
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

8.  Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.

Authors:  Khanh-Quynh N Nguyen; Wen-I Tsou; Daniel A Calarese; Stanley G Kimani; Sukhwinder Singh; Shelly Hsieh; Yongzhang Liu; Bin Lu; Yi Wu; Scott J Garforth; Steve C Almo; Sergei V Kotenko; Raymond B Birge
Journal:  J Biol Chem       Date:  2014-07-29       Impact factor: 5.157

9.  Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study.

Authors:  Tianfu Wu; Huihua Ding; Jie Han; Cristina Arriens; Chungwen Wei; Weilu Han; Claudia Pedroza; Shan Jiang; Jennifer Anolik; Michelle Petri; Ignacio Sanz; Ramesh Saxena; Chandra Mohan
Journal:  J Proteome Res       Date:  2016-06-07       Impact factor: 4.466

10.  The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.

Authors:  Daria Zdżalik-Bielecka; Agata Poświata; Kamila Kozik; Kamil Jastrzębski; Kay Oliver Schink; Marta Brewińska-Olchowik; Katarzyna Piwocka; Harald Stenmark; Marta Miączyńska
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.